Global AI Powered Cancer Test Market 2022-2027
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global AI Powered Cancer Test Market 2022-2027

Last Updated:  Apr 25, 2025 | Study Period: 2022-2027

GLOBAL AI POWERED CANCER TEST MARKET

 

INTRODUCTION

AI is particularly good at finding patterns in vast amounts of data, deriving correlations between complicated aspects in the data, and discovering properties in data (such as photos) that the human brain cannot see.

 

It has already shown success in radiology, where physicians employ computers to quickly interpret pictures, allowing radiologists to spend their attention on issues that require their technical judgement.

 

The FDA, for instance, authorized the first AI-based technology to interpret pictures quickly and aid radiologists in identifying breast cancer in routine mammography that year and.

 

infographic: AI Powered Cancer Test Market, AI Powered Cancer Test Market Size, AI Powered Cancer Test Market Trends, AI Powered Cancer Test Market Forecast, AI Powered Cancer Test Market Risks, AI Powered Cancer Test Market Report, AI Powered Cancer Test Market Share

 

GLOBAL AI POWERED CANCER TEST MARKET DEVELOPMENTS AND INNOVATIONS

S NoOverview of DevelopmentDevelopment DetailingRegion of DevelopmentPossible Future Outcomes
1AI projects are improving cancer screening and outcomesIn consequence, the World Economic Forum India's Centre for Fourth Industrial Revolution has launched a cancer-care initiative in collaboration with Microsoft.GlobalThis would enhance better Technological Controls
2Artificial intelligence is improving the detection of lung cancerEarly detection using machine learning algorithms might save lives.GlobalThis would enhance better Technological Controls
3Artificial Intelligence Help See Cancer in New, and Better, WaysWhen it comes to the convergence of artificial intelligence and cancer research, this model is only the beginning.GlobalThis would enhance better Technological Controls
4Artificial Intelligence in Cervical Cancer Screening and DiagnosisThey have fewer drawbacks, such as lower time consumption, fewer professional and technical people requirements, and no prejudice due to subjective considerations.GlobalThis would enhance better Technological Controls
5An AI-Powered Blood Test to Detect Cancer Using NanoDSFThis promising method may now be applied to different types of malignancies, potentially transforming it into a powerful pan-cancer diagnostic and monitoring tool that just requires a simple blood test.GlobalThis would enhance better Technological Controls

 

COMPETITIVE LANDSCAPE

Despite its widespread use, breast cancer screening is fraught with debate, according to the investigators: Detection techniques that are more aggressive are designed to maximise the advantages of timely identification, whilst screenings that are less frequent are designed to decrease false positives, anxiety, and expenditures for people who will never acquire breast cancer.

 

The researchers argue that in order to incorporate image-based risk models into clinical treatment and make them broadly available, the models needed both algorithmic enhancements and large-scale verification across numerous institutions to verify their reliability.

 

GE Healthcare is a leading mobiliser of the self-sensing composites solutions involving various industrial application and solutions requirements in the market. The GE Invenia ABUS 2.0, the first FDA-approved ultrasonography device providing supplementary screening in women with thick breasts, can offer radiologists with a quick and accurate screening tool to identify many malignancies that mammography may overlook throughout this patient group. The unique Reverse Curve transducer moves automatically to provide a three-dimensional picture from each breast.

 

AbbottLaboratories  is part of the component manufacture trending companies in the current industry. Its latest addition has been brought in through A machine-learning-based method might provide clinicians with a more personalised calculation, utilising an extreme kind of sickness that can develop swiftly and distributed throughout the body.

 

There is presently no screening test for bowel cancer serum in the United States. Physicians, on the other hand, frequently employ serum diagnostics testing to determine the existence of various disorders.

 

COMPANIES PROFILED

Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in theIndustry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2022-2027
18Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027
19Market Segmentation, Dynamics and Forecast by Application, 2022-2027
20Market Segmentation, Dynamics and Forecast by End use, 2022-2027
21Product installation rate by OEM, 2022
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2022
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix